GI

Galatea Bio Inc.

www.galatea.bio link_icon

Galatea Bio Market Research Report



Company Overview



Name


Galatea Bio

Mission


The mission of Galatea Bio is to leverage world-class ancestry algorithms to better understand underserved Latin American populations, maintaining a strong commitment to ethical research. Their goal is to expand the diversity of genetic datasets to accelerate discovery rates in genomics and improve health outcomes for underrepresented minorities.

Founded


2021

Founders


  • Carlos Bustamante, PhD

  • Nicholas Katsanis, PhD

  • Alexander Ioannidis, PhD


Key People


  • Carlos Bustamante, PhD - President & CEO

  • Nicholas Katsanis, PhD - Chief Scientific Officer (CSO)

  • Alexander Ioannidis, PhD - Chief Data Scientist

  • Eimear E. Kenny, PhD - Icahn School of Medicine at Mount Sinai

  • Teri Klein, PhD - Stanford University

  • Keolu Fox, PhD - University of California San Diego

  • Claes Wahlestedt, MD, PhD - University of Miami

  • Jacob McCauley, PhD - University of Miami

  • Jay Tischfield - Rutgers University

  • Jennifer Miller - Yale University

  • Michael Lee, PhD - VP of Biobank Operations

  • Andres Bustamante - VP of Finance and Administration

  • Kathleen Barnes, PhD - Senior Distinguished Scholar

  • Babak Moatamed, PhD - Director of Health Informatics

  • Arturo Lopez Pineda, PhD - Data Engineering Lead

  • Sonia Moreno Grau, PhD - Statistical Geneticist

  • Niki Mourtzi, PhD - Research Analyst

  • Sa Sheng - Manager of Operations


Headquarters


14350 Commerce Way, Miami Lakes, FL 33016, United States

Number of Employees


No information is available.

Revenue


No information is available.

Known For


Galatea Bio is known for building the largest data asset for population-driven genomics discovery and focusing on underrepresented populations in genetic research.

Products



Galatea Bio offers solutions under three main organizations:



GB Health


Focuses on building a clinical lab capable of delivering actionable results to partners in the clinic and pharma sectors.

GB Community


This is the foundational research offering in biobanking, with a flagship initiative called the Biobank of the Americas. The infrastructure can be expanded to other communities, focusing on diversity as a central tenet.

GB Discovery


Leverages the work in Health and Community solutions to deliver the next generation of algorithms and pharmaceutical targets.

Note: Detailed high-level descriptions and key features of each product are not available.

Recent Developments



Key Developments



Global Biobank Meta-analysis Initiative: Powering Genetic Discovery Across Human Disease


  • Date: October 14, 2022

  • Category: Community

  • Description: A collaborative network of 23 biobanks from 4 continents representing over 2.2 million individuals with genetic data linked to electronic health records. This initiative aims to integrate diverse biobanks to improve GWAS power for diseases and enable the nomination of disease genes and drug candidates.


XGMIX: Local-Ancestry Inference with Stacked XGBOOST


  • Date: October 14, 2022

  • Category: Discovery

  • Description: A method based on gradient-boosted trees for local ancestry inference that is simple, fast, and accurate. This tool addresses the under-representation of the world's populations in genetic association studies.


Neural ADMIXTURE: Rapid Population Clustering with Autoencoders


  • Date: October 14, 2022

  • Category: Discovery

  • Description: No detailed description available.


New Products


No information is available on new products launched.

New Features Added


No information is available on new features added to existing products.

New Partnerships


No information is available on new partnerships.

Contact Information



  • Address:

14350 Commerce Way, Miami Lakes, FL 33016, United States

  • Phone:

+1 754 233 3350

  • Email:

info@galatea.bio